Ledger.Open graph →

SEC Form D · Amendment · filed April 5, 2023

Vitro Biopharma, Inc

Offering

$2.5M

Sold

$993K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DENVER, CO

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Caroline R. Mosessian · Denver, COExec · Director John R. Packs · Denver, CODirector James R. Musick · Denver, COExec · Director Christopher Furman · Denver, COExec · Director Nathan Haas · Denver, COExec Kelvin C. Yap · Central, Hong KongExec · Director Thomas Gallucci · New York, NYExec · Director Philip Dore · New York, NYDirector Moses Adubi · New York, NYExec · Director Timothy E. Flower · London, United KingdomExec Tiana R. States · Denver, COExec William Hausberg · DARIEN, CTDirector Andre H. De Baubigny · Menlo Park, CAExec · Director Xufeng ". Hua · New York, NYExec · Director Joel A. Rudin · New York, NYExec · Director David J. Margulies · New York, NYExec Tiana R. States · Denver, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗